Search for: "Janssen Research "
Results 161 - 180
of 199
Sorted by Relevance
|
Sort by Date
16 Nov 2022, 5:00 am
This unsurprising decision, given the South’s prevalent use of preemption, impacted COVID-19 infection rates, and, as our new research suggests, COVID-19 vaccination and vaccination disparities. [read post]
2 Sep 2015, 8:19 am
So in the past we have seen drugs rushed on to the market without the internal research necessary to make sure they are safe. [read post]
5 Apr 2017, 1:00 am
Thus, “early certainty” is likely to be detrimental to innovation and furthering research, at least for several years to come. [read post]
2 Sep 2015, 8:19 am
So in the past we have seen drugs rushed on to the market without the internal research necessary to make sure they are safe. [read post]
6 Aug 2009, 6:50 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
24 Apr 2013, 8:31 am
The only current solution is research at the chambers level. [read post]
21 Feb 2021, 4:07 pm
Published in Internet Policy Review (18 December 2020), 9(4), pp 1 – 25; https://doi.org/10.14763/2020.4.1536 , Heleen Janssen, University of Cambridge – Computer Laboratory, Jennifer C [read post]
6 Sep 2016, 2:42 pm
Janssen, 100 So.3d 1239, 1240 (Fla. 2d DCA 2012). [read post]
5 Jan 2018, 12:00 pm
Categories: SGLT-2 Inhibitors Diabetes Drugs Hepatitis C Treatment Drugs Anticoagulants / Bloodthinners Breast Implants Osteoporosis Treatment Drugs Erectile Dysfunction (ED) Drugs Heartburn / Acid Reflux Drugs Multiple Sclerosis (MS) Treatment Drugs DPP-4 Inhibitors Diabetes Drugs Miscellaneous SGLT-2 Inhibitors Diabetes Drugs: Jardiance - Amputations Drug Safety Issue Remains Uncertain Due To Admitted "inherent limitations of... post hoc analyses" (11/28/17) Medical… [read post]
4 May 2011, 7:52 am
Barry Lipton, Chris Laws and Linda Li, “Narcotics in Workers Compensation,” NCCI Research Brief, December 2009 p.5. 8. [read post]
21 Dec 2022, 2:37 pm
Heleen Janssen, Michelle Seng Ah Lee and Jatinder Singh (all from the University of Cambridge) published an interesting piece on the fundamental rights assessments. [read post]
9 Nov 2015, 7:39 am
Merck argued: * the claims are excessively broad, because they cover any and all types of cancer but the specification does not make it plausible that all cancers can be treated by an anti-PD-1 antibody* the patent is not an enabling disclosure of an anti-PD-1 antibody which is suitable to treat all cancers--the most it does is set an unduly burdensome research project to find one* the patent does not disclose a pri [read post]
12 Apr 2007, 1:33 am
"More likely than not" seems to us to be farther away from the actual comfort level that professionals need before making a decision than the existing "reasonable professional certainty" standard.According to the Reporter's Notes (pp. 135-36), somebody did some ad hoc research among some doctors and scientists attending a recent medico-legal conference (not necessarily a representative sampling, we suspect, given the setting) by eliciting criticism of the… [read post]
14 Feb 2024, 10:36 am
” Quinton Feast, left, a digital navigator for the library, helps Luis Romano research on a computer in the community technology center at the Denver Public Library’s Central Library in downtown Denver on Jan. 31, 2024. [read post]
18 Nov 2016, 12:44 am
The need to undertake further research would amount to an “undue burden” being placed on the skilled addressee. [read post]
13 May 2010, 12:27 pm
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
5 Sep 2013, 12:24 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. [read post]
